POCARED Diagnostics is a Rehovot, Israel-based diagnostics and pre-analytical technology manufacturer focused on tools that help practitioners and hospitals practice evidence-based medicine while lowering laboratory operating costs. Its flagship product, the POCARED P-1000 analysis platform, delivers direct-specimen, fully automated, reagent-free detection, identification, and enumeration of bacteria and yeast through intrinsic fluorescence optical data. The company is also advancing its SP platform, though details of that system were not specified. Led by President and CEO Jonathan Gurfinkel, POCARED plans to complete clinical trials and scale manufacturing capacity as it prepares both platforms for commercialization. The company maintains additional offices in the United States. Recent funding activity indicates investors’ confidence in the technology’s commercial prospects, though no operating metrics such as revenue or user counts were disclosed.

Total raised

$65M

Funding rounds

2

Latest round

Equity

Latest activity

Jul 2021